Gain Therapeutics Inc (GANX)
2.51
-8.39%
Gain Therapeutics Inc (GANX) is currently trading at $2.51. This represents a loss of 8.39% from the previous session. With a market capitalization of $0.10B, GANX is a key component of the Health Care sector. Investors looking to trade GANX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade GANX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Gain Therapeutics Inc (GANX) shows a bearish trend. Analysts are watching the 2.79 level closely.
Fundamentals
Mkt Cap0.10B
P/E Ratio0.0000
Volume993,215
60-Day Technical Chart
Advanced Charting
Need more indicators for GANX? Use the world's #1 platform.
Open GANX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $3
| Metric |
GANX -8.39% |
RR +5.06% |
ALLO +8.95% |
ASPN -28.09% |
|---|---|---|---|---|
| Price | $2.51 | $2.70 | $2.49 | $2.57 |
| Mkt Cap | $0.10B | $0.61B | $0.55B | $0.22B |
| - | View → | View → | View → |
Latest Headlines
Here's Why Gain Therapeutics, Inc. (GANX) is a Great Momentum Stock to Buy
Yahoo Finance • Dec 8, 2025
Parkinson’s patients see sharp drop in harmful brain marker in trial
Stock Titan • Jan 6, 2026
Gain Therapeutics: Valuation Remains Low In Light Of Recently Reported Functional Improvement In PD Patients
Seeking Alpha • Nov 7, 2025
Gain Therapeutics stock falls after announcing public offering
Investing.com • Jul 15, 2025
Gain Therapeutics Reports Encouraging Phase 1b Parkinson’s Data
TipRanks • Dec 18, 2025
● Gemini Agentic AI Analyst Insight for GANX
Market Education
- I want to day trade, which technical analysis indicators work best. Jul 15, 2023
- I am a newbie Trader, how do I start trading Jul 15, 2023
- These Whales are taking all the Ape money - aka Large Fund Mgmt Companies Jul 17, 2023
External Research